当前位置：首页>产品中心>单抗/多抗>Anti-Human IL17A & TNFSF13B Bispecific Reference Antibody|抗人IL-17A和TNFSF13B双特异性参考抗体(靶标：人IL-17A/BAFF)
Anti-Human IL17A & TNFSF13B Bispecific Reference Antibody|抗人IL-17A和TNFSF13B双特异性参考抗体(靶标：人IL-17A/BAFF)
- 货号：RB9THS856106
- 价格：面议
- 点击：234
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Humanized |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG4-kappa-[scFv]2 |
| 纯度 | >95% as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 0.71 mg/ml |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 表达系统 | Mammalian Cells |
| 登录号 | Q16552 & Q9Y275 |
| 背景信息 | Tibulizumab (LY-3090106) is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. |
| 别名 | Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3 |
| 种属 | Human |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品: